Anbio Biotech IVROU Rapid COVID-19 Antigen Test(Colloidal Gold)
Anbio Biotech IVROU Rapid COVID-19 Antigen Test(Colloidal Gold)
Anbio Biotech IVROU Rapid COVID-19 Antigen Test(Colloidal Gold)
Anbio Biotech IVROU Rapid COVID-19 Antigen Test(Colloidal Gold)
Anbio Biotech IVROU Rapid COVID-19 Antigen Test(Colloidal Gold)

Anbio Biotech IVROU Rapid COVID-19 Antigen Test(Colloidal Gold)

Model NO.
IRSJ-03
Price:
€ 35.00-50.00 / box
Delivery:
FOB
Quantity:

Product nameRapid COVID-19 Antigen Test(Colloidal Gold)

Package and Specification:1PCS/box, 500BOX/carton, 6000PCS/pallet

Intended Use:

The antigen is generally detectable in upper respiratory samples or lower respiratory samples during the acute phase of infection.

The positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. The positive results do not rule out bacterial infection or co-infection with other viruses. The antigen detected may not be the definite cause of disease.

The negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions,and confirmed with a molecular assay, if necessary.

Method:

1. The test should be operated at room temperature(15-30℃).

2. Add the specimens

Saliva Specimen:

Open the lid and absorb a tube of liquid with a disposable dropper. drip 3 drops of extraction solution into the sample well of the Test Card, and start the timer. Read the results at 15~20 minutes.

Positive Test:

Positive for the presence of SARS-CoV-2 antigen. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The antigen detected may not be the definite cause of disease.

Negative Test :

Negative results are presumptive. Negative test results do not preclude infection and should not be used as the sole basis for treatment or other patient managementdecisions, including infection control decisions, particularly in the presence of clinical signs and symptoms consistent with COVID-19, or in those who have been in contact with the virus. It is recommended that these results would be confirmed by amolecular testing method, if necessary, for patient management Control.

Invalid:

Do not report results. Repeat the test.

Certification: CE-certificate,ISO-certificate,CIBG-certificate

Send Message

*
* clear input
* clear input
* clear input
customer-service Customer Service
message Message
go top Top
Scan the QR code Close
qr code
qrcode

Send Message

*
* clear input
* clear input
* clear input
Choose language